The peptidylglycine-α-amidating monooxygenase (PAM) gene rs13175330 A>G polymorphism is associated with hypertension in a Korean population

[1]  H. J. Yoo,et al.  Estrogen-related receptor γ gene (ESRRG) rs1890552 A>G polymorphism in a Korean population: Association with urinary prostaglandin F2α concentration and impaired fasting glucose or newly diagnosed type 2 diabetes. , 2017, Diabetes & metabolism.

[2]  Minkyung Kim,et al.  Influence of estrogen-related receptor γ (ESRRG) rs1890552 A > G polymorphism on changes in fasting glucose and arterial stiffness , 2017, Scientific Reports.

[3]  S. Choi,et al.  Introns: The Functional Benefits of Introns in Genomes , 2015, Genomics & informatics.

[4]  Tubao Yang,et al.  GRK5 Intronic (CA)n Polymorphisms Associated with Type 2 Diabetes in Chinese Hainan Island , 2014, PloS one.

[5]  Kari Stefansson,et al.  Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes , 2014, Nature Genetics.

[6]  S. Visvikis-Siest,et al.  Genetic biomarkers of hypertension and future challenges integrating epigenomics. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[7]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[8]  J. Mi,et al.  Physical activity modifies the associations between genetic variants and hypertension in the Chinese children. , 2012, Atherosclerosis.

[9]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[10]  W. Sadee,et al.  Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs , 2011, The Pharmacogenomics Journal.

[11]  A. Dominiczak,et al.  GENOME WIDE ASSOCIATION STUDY OF BLOOD PRESSURE EXTREMES IDENTIFIES VARIANT IN UMOD ASSOCIATED WITH HYPERTENSION: 6B.01 , 2010 .

[12]  M. Nagarkatti,et al.  Unique SNP in CD44 intron 1 and its role in breast cancer development. , 2010, Anticancer research.

[13]  Andrew D. Johnson,et al.  Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.

[14]  S. Roth.  Genetics Primer for Exercise Science and Health , 2007 .

[15]  J. Witteman,et al.  Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes , 2007, Journal of hypertension.

[16]  J. Mehta,et al.  Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. , 2006, The international journal of biochemistry & cell biology.

[17]  R. Mains,et al.  Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. , 2005, Developmental biology.

[18]  N. Bäck,et al.  Peptidylglycine-α-amidating monooxygenase and pro-atrial natriuretic peptide constitute the major membrane-associated proteins of rat atrial secretory granules , 2003 .

[19]  T. Teramoto,et al.  Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. , 2003, Journal of atherosclerosis and thrombosis.

[20]  G. Sagnella.  Atrial natriuretic peptide mimetics and vasopeptidase inhibitors. , 2001, Cardiovascular research.

[21]  W. Sadee,et al.  CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing. , 2016, Pharmacogenetics and genomics.

[22]  F. Amiri,et al.  Regulation of natriuretic peptide secretion by the heart. , 1999, Annual review of physiology.

[23]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.